Details
- Close date
- Monday, 9 June 2025
- Academic background
- Health Sciences
- Host campus
- Dunedin
- Qualifications
- Postgraduate Diploma, Honours, Master's, PhD
- Department
- Pathology (Dunedin)
- Supervisors
- Associate Professor, Pathology Tania Slatter, Dr, Ophthalmology, Medicine Department Francesc March
Overview
Retina research is an exciting field. It has the potential to make a real difference in people's lives, fighting vision loss and blindness. Retinal diseases are becoming increasingly common as our population ages, and they can significantly impact a person's quality of life. Retina research has the potential to lead to new treatments and therapies that can slow, stop, or even reverse the damage caused by these diseases. One of the great things about retina research is that you can see results in the short term. Because the retina is a relatively small system, it is possible to carry out experiments and observe changes relatively quickly.
Finally, one of the most exciting aspects of retina research is that the results of this research can be directly applied to patient care. It is possible to translate research findings into new treatments and therapies that can be used to improve patient outcomes. One exciting opportunity for this role is the possibility of collaborating with pharmaceutical companies to test and develop new drugs for retinal diseases. As a researcher in this field, you will gain valuable experience and expertise that may make you an attractive candidate for academia and industry positions. There are a number of projects available please contact us for this opportunity.
Useful information
Similar research opportunities
- A phoenix from the ashes: Do dying cancer cells induce drug-tolerance in lung cancer?
- A role for untranslated p53 mRNA in drug resistance
- Characterisation of YB-1 interactions with the cytoskeleton using live cell imaging
- Characteristion of YB-1 interactions with the cytoskeleton using live cell imaging
- Comprehensive characterization of uncommon TP53 mutations in cancer